236 related articles for article (PubMed ID: 16251996)
1. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury.
Araki K; Shiotani A; Watabe K; Saito K; Moro K; Ogawa K
Gene Ther; 2006 Feb; 13(4):296-303. PubMed ID: 16251996
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus.
Moro K; Shiotani A; Watabe K; Takeda Y; Saito K; Mori Y; Ogawa K
Brain Res; 2006 Mar; 1076(1):1-8. PubMed ID: 16473328
[TBL] [Abstract][Full Text] [Related]
3. Delivery of an adenoviral vector to the crushed recurrent laryngeal nerve.
Rubin A; Mobley B; Hogikyan N; Bell K; Sullivan K; Boulis N; Feldman E
Laryngoscope; 2003 Jun; 113(6):985-9. PubMed ID: 12782809
[TBL] [Abstract][Full Text] [Related]
4. A novel drug therapy for recurrent laryngeal nerve injury using T-588.
Mori Y; Shiotani A; Saito K; Araki K; Ikeda K; Nakagawa M; Watabe K; Ogawa K
Laryngoscope; 2007 Jul; 117(7):1313-8. PubMed ID: 17507828
[TBL] [Abstract][Full Text] [Related]
5. Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapy.
Rubin AD; Hogikyan ND; Oh A; Feldman EL
Laryngoscope; 2012 Feb; 122(2):349-55. PubMed ID: 22241608
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.
Kato R; Wolfe D; Coyle CH; Huang S; Wechuck JB; Goins WF; Krisky DM; Tsukamoto T; Nelson JB; Glorioso JC; Chancellor MB; Yoshimura N
Gene Ther; 2007 Sep; 14(18):1344-52. PubMed ID: 17611585
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral gene transfer of glial cell line-derived neurotrophic factor to injured adult motoneurons.
Watabe K; Sakamoto T; Ohashi T; Kawazoe Y; Oyanagi K; Takeshima T; Inoue K; Eto Y; Kim SU
Hum Cell; 2001 Mar; 14(1):7-15. PubMed ID: 11436355
[TBL] [Abstract][Full Text] [Related]
8. Observations of recurrent laryngeal nerve injury and recovery using a rat model.
Tessema B; Roark RM; Pitman MJ; Weissbrod P; Sharma S; Schaefer SD
Laryngoscope; 2009 Aug; 119(8):1644-51. PubMed ID: 19504559
[TBL] [Abstract][Full Text] [Related]
9. Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor.
Watabe K; Ohashi T; Sakamoto T; Kawazoe Y; Takeshima T; Oyanagi K; Inoue K; Eto Y; Kim SU
J Neurosci Res; 2000 May; 60(4):511-9. PubMed ID: 10797554
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral GDNF gene transfer prevents motoneuron loss in the nucleus ambiguus.
Saito K; Shiotani A; Watabe K; Moro K; Fukuda H; Ogawa K
Brain Res; 2003 Feb; 962(1-2):61-7. PubMed ID: 12543456
[TBL] [Abstract][Full Text] [Related]
11. Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
Do Thi NA; Saillour P; Ferrero L; Paunio T; Mallet J
Gene Ther; 2007 Mar; 14(5):441-50. PubMed ID: 17093508
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia.
Chou AK; Yang LC; Wu PC; Wong WT; Liu GS; Chen JT; Howng SL; Tai MH
Brain Res Mol Brain Res; 2005 Feb; 133(2):198-207. PubMed ID: 15710236
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for laryngeal paralysis.
Shiotani A; Saito K; Araki K; Moro K; Watabe K
Ann Otol Rhinol Laryngol; 2007 Feb; 116(2):115-22. PubMed ID: 17388235
[TBL] [Abstract][Full Text] [Related]
14. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats.
Hermann DM; Kilic E; Kügler S; Isenmann S; Bähr M
Neurobiol Dis; 2001 Dec; 8(6):964-73. PubMed ID: 11741392
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage.
Tsai TH; Chen SL; Chiang YH; Lin SZ; Ma HI; Kuo SW; Tsao YP
Exp Neurol; 2000 Dec; 166(2):266-75. PubMed ID: 11085892
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor.
Baumgartner BJ; Shine HD
Exp Neurol; 1998 Sep; 153(1):102-12. PubMed ID: 9743571
[TBL] [Abstract][Full Text] [Related]
18. Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer.
Natsume A; Wolfe D; Hu J; Huang S; Puskovic V; Glorioso JC; Fink DJ; Mata M
Exp Neurol; 2003 Dec; 184(2):878-86. PubMed ID: 14769380
[TBL] [Abstract][Full Text] [Related]
19. Development and characterisation of an experimental recurrent laryngeal nerve injury model for the study of viral gene therapy.
Fung K; Hogikyan ND; Heavner SB; Ekbom D; Feldman EL
J Laryngol Otol; 2008 May; 122(5):500-5. PubMed ID: 17592655
[TBL] [Abstract][Full Text] [Related]
20. Collateral reinnervation by the superior laryngeal nerve after recurrent laryngeal nerve injury.
Hydman J; Mattsson P
Muscle Nerve; 2008 Oct; 38(4):1280-9. PubMed ID: 18816603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
